2015 REVIEW: China - Quality The Watchword In String Of CFDA Reforms
This article was originally published in PharmAsia News
2015 has seen a plethora of regulatory changes and policy rewinding for China, by many measures now the world's largest pharmaceutical market. If you missed some of the major news during the year, here is your opportunity to check out the top China pharma regulatory happenings in 2015 with the help of one easy to digest infographic.
Register for our free email digests: